Edinburgh, United Kingdom, August 22, 2014 --(PR.com
)-- Commenting, Dr Michael Roberts, Founder and CSO, said: “We have now shown that our highly disruptive technology platform can be extended from human life science into plant science. Whilst this was always expected, we now have evidence of the wide applicability of the platform. We have created at least one promoter that mediates gene expression to levels higher than is achievable with the ubiquitin-1 promoter, which is widely acknowledged as a high expressing promoter in plants. While high expression is not always the main goal, we have also proven that we can rationally design effective synthetic plant promoters. This represents a major step forward for the company and the application of our technology in the AgBio industry. Based on this success we are now moving ahead with important new plant science projects though partnerships, with a view to addressing the major challenges that face the industry.”
Synpromics Limited is based in NINE, Bioquarter, Edinburgh and has a highly renowned Scientific Advisory Board including Professor Jonathan Jones (Sainsbury Laboratory), Dr David Lawrence (ex CSO of Syngenta) and Professor David Hume (Director of the Roslin Institute).